Up to 40% of people with heart failure may benefit from therapies targeting inflammation

High inflammatory risk was estimated to be present in nearly 40% of patients with heart failure and was closely tied to signals of cardio-kidney-metabolic syndrome such as more severe HF, obesity and kidney disease, researchers reported. Independent predictors of elevated high-sensitivity C-reactive protein were similar across HF subtypes, including HF with preserved ejection fraction, HF